...Regenerative medicine company Orig3n Inc. (Boston, Mass.) said it had an initial close of a series B...
...an initial close of a series B round led by Haitong International. A spokesperson for Orig3n...
...and Clearing Ltd. (HKEX) (see "Stealth, AOBiome Propose Hong Kong Offerings" ). Orig3n Inc., Boston, Mass. Sandi Wong Orig3n Inc....

...Regenerative medicine company Orig3n Inc. (Boston, Mass.) said it had an initial close of a series B...
...said it had an initial close of a series B round led by Haitong International. Orig3n...
...a $12.5 million series A co-led by Hatteras Venture Partners and Syno Capital in 2015. Orig3n...

...its goal of banking cells from one million donors, induced pluripotent stem (iPS) cell provider Orig3n Inc....
...However, finding superdonors is challenging, as they are few and far between. Founded in 2014, Orig3n...
...disease foundation meetings to professional sporting events and technology conferences. Unlike other cell banking companies, Orig3n...

...its proprietary reprogramming technologies and a bank of cells derived from nearly one million people, Orig3n Inc....
...could get 10 vials of cells from different patients?" Smith declined to disclose details about Orig3n's...
...has identified. Companies and Institutions Mentioned Orig3n Inc., Boston, Mass. Sidebars Orig3n Inc., Corporate Profile BC Staff Orig3n Inc....